Skip to content

Pharmaceutical industries Advice: what changed

BE 0883.798.672NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2022 and 2025

not consecutive
Net result for the year
-€2,949
2022 · €3,960-€6,910
Equity
€26,726
2022 · €123,036-€96,310
Cash
€19,467
2022 · €66,046-€46,579
Balance sheet total
€27,340
2022 · €228,077-€200,737

Largest movements

2022 to 2025
Assets
  • Receivables within one year -€86,489

    down €86,489 (-94.6%), from €91,428 to €4,940

    of which Trade receivables: -€78,158

  • Stocks and contracts -€64,221

    no longer reported in 2025; in 2022 it stood at €64,221

  • Cash -€46,579

    down €46,579 (-70.5%), from €66,046 to €19,467

  • Financial fixed assets -€3,012

    down €3,012 (-72.4%), from €4,160 to €1,148

Equity and liabilities
  • Trade debts -€104,836

    down €104,836 (-100.0%), from €104,858 to €22

  • Profit (loss) carried forward -€96,310

    down €96,310 (-88.5%), from €108,796 to €12,486

Income statement
  • Financial income -€5,415

    down €5,415 (-97.5%), from €5,555 to €140

  • Gross operating margin -€4,356

    down €4,356, from €4,284 to -€72

  • Depreciation -€4,040

    down €4,040 (-96.2%), from €4,200 to €160

  • Other operating charges +€630

    up €630 (+62.0%), from €1,016 to €1,646

  • Financial charges +€317

    up €317 (+66.0%), from €480 to €797

Change in the result, 2022 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2022 €3,960
Gross operating margin -€4,356
Depreciation +€4,040
Other operating charges -€630
Financial income -€5,415
Financial charges -€317
Taxes -€232
Result 2025 -€2,949
raises the resultlowers the result

Derived cash bridge

cash 2022 to 2025

A cash bridge needs two consecutive financial years. One year's result and depreciation cannot explain a change over several years. Pick two years that follow each other.

Every line side by side 40 lines
Line Code 2022 2025 Change %
Total assets 20/58 €228,077 €27,340 -€200,737 -88.0%
Fixed assets 21/28 €4,852 €1,360 -€3,492 -72.0%
Tangible fixed assets 22/27 €692 €212 -€480 -69.4%
Furniture and vehicles 24 €692 €212 -€480 -69.4%
Financial fixed assets 28 €4,160 €1,148 -€3,012 -72.4%
Current assets 29/58 €223,225 €25,980 -€197,245 -88.4%
Stocks and contracts in progress 3 €64,221 - -€64,221
Stocks 30/36 €64,221 - -€64,221
Amounts receivable within one year 40/41 €91,428 €4,940 -€86,489 -94.6%
Trade receivables 40 €80,343 €2,185 -€78,158 -97.3%
Other amounts receivable 41 €11,085 €2,755 -€8,331 -75.1%
Cash at bank and in hand 54/58 €66,046 €19,467 -€46,579 -70.5%
Deferred charges and accrued income 490/1 €1,530 €1,573 +€43 +2.8%
Total equity and liabilities 10/49 €228,077 €27,340 -€200,737 -88.0%
Equity 10/15 €123,036 €26,726 -€96,310 -78.3%
Contributions 10/11 €12,380 €12,380 = 0.0%
Reserves 13 €1,860 €1,860 = 0.0%
Non-distributable reserves 130/1 - €1,860 +€1,860
Reserves not available under the articles 1311 - €1,860 +€1,860
Distributable reserves 133 €1,860 - -€1,860
Profit (loss) carried forward 14 €108,796 €12,486 -€96,310 -88.5%
Amounts payable 17/49 €105,041 €614 -€104,427 -99.4%
Amounts payable within one year 42/48 €105,041 €614 -€104,427 -99.4%
Trade debts 44 €104,858 €22 -€104,836 -100.0%
Suppliers 440/4 €104,858 €22 -€104,836 -100.0%
Taxes, remuneration and social security 45 €182 €591 +€409 +224%
Taxes 450/3 €182 €591 +€409 +224%
Non-recurring operating income 76A - €2,422 +€2,422
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €4,200 €160 -€4,040 -96.2%
Other operating charges 640/8 €1,016 €1,646 +€630 +62.0%
Gross operating margin 9900 €4,284 -€72 -€4,356
Operating profit (loss) 9901 -€932 -€1,878 -€946 -101%
Financial income 75/76B €5,555 €140 -€5,415 -97.5%
Recurring financial income 75 €5,555 €140 -€5,415 -97.5%
Financial charges 65/66B €480 €797 +€317 +66.0%
Recurring financial charges 65 €480 €797 +€317 +66.0%
Profit (loss) for the period before taxes 9903 €4,143 -€2,535 -€6,678
Income taxes 67/77 €182 €414 +€232 +127%
Profit (loss) for the period 9904 €3,960 -€2,949 -€6,910
Profit (loss) for the period to be appropriated 9905 €3,960 -€2,949 -€6,910

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€26,726 to €26,726

Midpoint €26,726 · adjusted equity only

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €26,726
Indication €26,726

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€26,726
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€26,726

Capitalised earnings

net result for the year (9904)
2025
-€2,949
excluding non-recurring income and charges
-€5,372
2022
€3,960
2020
-€21,395
2019
-€1,364
2018
€20,751
Average result, excluding non-recurring income and charges
-€7,602
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2022 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.